Impact of corticosteroid treatment on clinical outcomes of influenza-associated ARDS: a nationwide multicenter study
Open Access
- 27 February 2020
- journal article
- research article
- Published by Elsevier in Annals of Intensive Care
- Vol. 10 (1) , 26-10
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Designing and conducting a randomized trial for pandemic critical illness: the 2009 H1N1 influenza pandemicIntensive Care Medicine, 2011
- Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis*Critical Care Medicine, 2009
- Hydrocortisone Therapy for Patients with Septic ShockNew England Journal of Medicine, 2008
- Stress doses of hydrocortisone in septic shock: beneficial effects on opsonization-dependent neutrophil functionsIntensive Care Medicine, 2007
- Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemiaNature Medicine, 2006
- Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2006
- Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old DrugsNew England Journal of Medicine, 2005
- Avian Influenza A (H5N1) Infection in HumansNew England Journal of Medicine, 2005
- Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic ShockJAMA, 2002